Feb 24, 2026 10:32AM
Feb 24, 2026 09:04AM
Feb 24, 2026 08:51AM
Feb 24, 2026 05:40AM
Feb 23, 2026 12:32PM
Feb 23, 2026 12:17PM
Feb 23, 2026 08:04AM Axsome Therapeutics (AXSM) Tops Q4 EPS by 17c
Feb 2, 2026 09:00AM
Jan 20, 2026 06:39AM
Jan 16, 2026 08:30AM
Jan 14, 2026 06:56AM
Jan 13, 2026 04:52AM
Jan 12, 2026 07:08AM
Jan 8, 2026 03:37AM Morgan Stanley Downgrades Axsome Therapeutics (AXSM) to Equalweight
Jan 5, 2026 07:08AM
Jan 5, 2026 06:40AM
Jan 2, 2026 09:37AM
Jan 2, 2026 08:53AM
Jan 2, 2026 06:23AM
Dec 31, 2025 01:54PM
Dec 31, 2025 01:20PM Leerink on Axsome Therapeutics (AXSM): 'This is very positive news'
Dec 31, 2025 01:19PM
Dec 31, 2025 12:42PM
Dec 31, 2025 12:19PM
Dec 31, 2025 08:27AM
Dec 31, 2025 08:25AM
Dec 31, 2025 08:24AM
Dec 31, 2025 06:55AM Axsome receives FDA feedback supporting AXS-12 narcolepsy drug filing
Dec 21, 2025 08:00PM
Nov 6, 2025 07:02AM
Nov 6, 2025 07:01AM
Nov 3, 2025 04:51PM
Nov 3, 2025 02:39PM
Nov 3, 2025 07:11AM
Oct 1, 2025 02:51AM B.Riley Starts Axsome Therapeutics (AXSM) at Buy
Sep 17, 2025 07:32AM
Sep 16, 2025 07:19AM
Sep 10, 2025 09:16AM
Sep 3, 2025 02:41AM
Aug 22, 2025 06:53AM
Aug 21, 2025 06:16AM
Aug 20, 2025 09:36AM Axsome Therapeutics (AXSM) Stock Has 45% Upside, per RBC Capital
Aug 4, 2025 07:34AM
Jul 22, 2025 07:28AM
Jul 22, 2025 06:38AM
Jul 18, 2025 09:58AM
Jul 7, 2025 07:02AM
Jul 3, 2025 06:39AM
Jun 10, 2025 09:24AM Piper Sandler Reiterates Overweight Rating on Axsome Therapeutics (AXSM)
Jun 10, 2025 06:39AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All